William Riedl

机构：UL Research Institutes, Endokrinologikum

发表论文 7 篇 · 总被引 509 次 · h-index 3

代表论文

• ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity (2021 · Nature Microbiology · 被引 330)
• Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity (2019 · Cell Host & Microbe · 被引 144)
• ISG15-dependent Activation of the RNA Sensor MDA5 and its Antagonism by the SARS-CoV-2 papain-like protease (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 35)
• Design of an innovative clinical development program using randomized controlled phase 2 trial data and real-world evidence from an expanded access protocol to assess mifomelatide (TCMCB07) in GI cancer cachexia. (2026 · Journal of Clinical Oncology)
• Abstract CT219: A randomized, double-blind, placebo-controlled Phase 2 study of mifomelatide (TCMCB07) in patients with newly diagnosed metastatic colorectal cancer undergoing chemotherapy: The Paradox Trial (2026 · Cancer Research)
• Flaviviral Antagonism of RIG-I-like Receptor-Based Immunity (2020 · University of Chicago)